A Southwest Florida Republican congressman is backing a proposal to have pharmaceutical companies have more transparency when they want to raise drug prices.
This week, U.S. Rep. Francis Rooney, R-Fla., joined U.S. Sens. Tammy Baldwin, D-Wisc., and Mike Braun, R-Ind., and U.S. Rep. Jan Schakowsky, D-Ill., in bringing out the “FAIR Drug Pricing Act” which, they insist, will be “the first step in addressing skyrocketing prescription drug prices by requiring transparency for pharmaceutical corporations that plan to increase drug prices.”